Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2022-03-11 00:00:00 ET · period of report 2022-03-10 · accession 0001209191-22-018291 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-11 | 2022-03-10 | RLAY | Bergstrom Donald A | Pres, R, D | S - Sale+OE | $25.00 | -10.0K | 94.9K | -10% | -$250.0K |
| D | 2022-03-11 | 2022-03-10 | RLAY | Bergstrom Donald A | Pres, R, D | M - OptEx | $4.12 | +10.0K | 104.9K | +11% | +$41.2K |
| D | 2022-03-11 | 2022-03-10 | RLAY | Bergstrom Donald A | Pres, R, D | M - OptEx | $0.00 | -10.0K | 227.5K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-10 | S | D | 10,000 | $25.00 | 94,926 | D | — | — | (F2) Includes 93,387 shares underlying restricted stock units. |
| 2 | Common | Common Stock | 2022-03-10 | M | A | 10,000 | $4.12 | 104,926 | D | — | — | (F2) Includes 93,387 shares underlying restricted stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-10 | M | D | 10,000 | $0.00 | 227,456 | D | $4.12 · — to 2028-04-09 | 10,000 Common Stock | (F3) Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. |